Literature DB >> 2745395

A case study of the cognitive and behavioral deficits of temporal lobe damage in herpes simplex encephalitis.

M K Greer1, M Lyons-Crews, L B Mauldin, F R Brown.   

Abstract

Herpes simplex viral encephalitis is a fairly common nonepidemic encephalitis which produces severe neurological sequelae in survivors. Most viral infections of the central nervous system produce diffuse damage, but the herpes simplex virus demonstrates a predilection for localization in the temporal and orbitofrontal regions of the brain. This case study illustrates the highly significant language difficulties, marked memory deficits, and propensity for physical aggression following temporal lobe damage brought about by herpes encephalitis, and presents the usefulness of a new diagnostic measure in delineating such a variable cognitive pattern.

Entities:  

Mesh:

Year:  1989        PMID: 2745395     DOI: 10.1007/bf02211849

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  15 in total

1.  Analyses of global memory impairments of different etiologies.

Authors:  S Corkin; N J Cohen; E V Sullivan; R A Clegg; T J Rosen; R H Ackerman
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

2.  Herpesvirus infections of the human central nervous system.

Authors:  L C Olson; E L Buescher; M S Artenstein; P D Parkman
Journal:  N Engl J Med       Date:  1967-12-14       Impact factor: 91.245

3.  Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis.

Authors:  C Gillberg
Journal:  J Autism Dev Disord       Date:  1986-09

4.  Reading recovery following herpes encephalitis.

Authors:  C D Rogers; P Peters
Journal:  J Learn Disabil       Date:  1979-11

5.  Different patterns of mnemonic deficits in two organic amnestic syndromes.

Authors:  S Mattis; R Kovner; E Goldmeier
Journal:  Brain Lang       Date:  1978-09       Impact factor: 2.381

6.  Computed tomography in young children with herpes simplex virus encephalitis.

Authors:  T Sugimoto; M Woo; H Okazaki; N Nishida; T Hara; A Yasuhara; M Kasahara; Y Kobayashi
Journal:  Pediatr Radiol       Date:  1985

7.  Autism and congenital cytomegalovirus.

Authors:  E G Stubbs; E Ash; C P Williams
Journal:  J Autism Dev Disord       Date:  1984-06

8.  Host genetics and the behavioral sequelae to herpes encephalitis in mice.

Authors:  D J McFarland; J Hotchin
Journal:  Physiol Behav       Date:  1983-06

9.  Acquired reversible autistic syndrome in acute encephalopathic illness in children.

Authors:  G R DeLong; S C Bean; F R Brown
Journal:  Arch Neurol       Date:  1981-03

10.  Incomplete Kluver-Bucy syndrome and fluent aphasia.

Authors:  A Arlazoroff; C L Carpel; H Zonis; E Goldenberg; E Zekler
Journal:  Brain Lang       Date:  1984-11       Impact factor: 2.381

View more
  5 in total

1.  Brief report: autism and herpes simplex encephalitis.

Authors:  M Ghaziuddin; L Y Tsai; L Eilers; N Ghaziuddin
Journal:  J Autism Dev Disord       Date:  1992-03

Review 2.  Autistic disorder and viral infections.

Authors:  Jane E Libbey; Thayne L Sweeten; William M McMahon; Robert S Fujinami
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

3.  Behavioral characterization of cereblon forebrain-specific conditional null mice: a model for human non-syndromic intellectual disability.

Authors:  Anjali M Rajadhyaksha; Stephen Ra; Sarah Kishinevsky; Anni S Lee; Peter Romanienko; Mariel DuBoff; Chingwen Yang; Bojana Zupan; Maureen Byrne; Zeeba R Daruwalla; Willie Mark; Barry E Kosofsky; Miklos Toth; Joseph J Higgins
Journal:  Behav Brain Res       Date:  2011-10-04       Impact factor: 3.332

4.  Brief report: autistic disorder in three children with cytomegalovirus infection.

Authors:  Thayne L Sweeten; David J Posey; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2004-10

Review 5.  Viral encephalitis: neuropsychiatric and neurobehavioral aspects.

Authors:  David B Arciniegas; C Alan Anderson
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 8.081

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.